Federal award
GRIFOLS USA LLC
W81K0012C0038
Contract
Obligated and Ceiling
- Obligated (net)
- $274,679.00
- Ceiling (potential value, not spending)
- $457,813.40
- Current value
- $274,679.00
- Gross positive obligations
- $282,309.60
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- GRIFOLS USA LLC · D48FNWJCJ5H5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- GRIFOLS SA · G9PNB5K6E1U8
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0012C0038
- Award type code
- D
- Actions
- 11 · Jul 19, 2012 to Sep 15, 2015
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History11
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 15, 2015 | FY2015 | P00010 | C | −$7,630.60 | — |
| Jul 9, 2015 | FY2015 | P00009 | M | $0.00 | — |
| Mar 12, 2015 | FY2015 | P00008 | G | $0.00 | — |
| Oct 14, 2014 | FY2015 | P00007 | C | $91,567.20 | — |
| Jun 23, 2014 | FY2014 | P00006 | G | $0.00 | — |
| Jan 10, 2014 | FY2014 | P00005 | C | $99,175.20 | — |
| Oct 3, 2013 | FY2014 | P00004 | D | $0.00 | — |
| Jul 23, 2013 | FY2013 | P00003 | W | $0.00 | — |
| Nov 7, 2012 | FY2013 | P00002 | C | $91,567.20 | — |
| Jul 23, 2012 | FY2012 | P00001 | M | $0.00 | — |
| Jul 19, 2012 | FY2012 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.